BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2014
View Archived Issues
Synergism observed with dabrafenib and trametinib combination in melanoma
Read More
Discovery of BRD-3444, a new antimalarial by diversity-oriented synthesis strategy
Read More
Novartis cancels launch in Japan of Rasilamlo combination tablets LD and HD
Read More
Phase III trial of entinostat begins in advanced breast cancer
Read More
Pfizer reports data from phase III study of Xalkori in NSCLC
Read More
Med BioGene confirms CLIA approval for GeneFx Lung
Read More
Rosetta Genomics collaborates with Clalit Health Services' Rabin Medical Center
Read More
Myriad Genetics and Tesaro form HRD companion diagnostic collaboration
Read More
Cellceutix initiates trial of Prurisol for psoriasis
Read More
PI3K signaling pathway implicated in uterine carcinosarcoma
Read More
DMC recommends that COMET-1 study continue to completion
Read More
Mologen initiates lung cancer trial of MGN-1703 in Belgium
Read More
NIH funds new research consortium for Ebola virus
Read More
New PI3K inhibitors disclosed by Roche and Genentech
Read More
Janssen R&D Ireland prepares novel compounds for HBV infection
Read More
Researchers at Gruenenthal disclose novel calcium channel blockers
Read More
Canadian group presents new antibacterial agents
Read More
e-Therapeutics recommences patient recruitment in phase I U.K. trial of ETS-2101
Read More
LEO-43204 demonstrates efficacy against actinic keratosis in a first-in-human clinical trial
Read More
CXD-101 and companion diagnostic studied in new phase I trial
Read More
Daiichi Sankyo announces East Asian subgroup analyses from edoxaban trials
Read More
Onconova presents in vivo data for ON-146040
Read More
Genocea reports updated results from phase I/IIa HSV-2 study of GEN-003
Read More
GlaxoSmithKline receives Japanese approval of its nucleic acid analogue for HBV
Read More
Albiglutide approved in Europe for type 2 diabetes
Read More
FDA accepts NDA for migraine candidate AVP-825
Read More